Gerd Maass

1.1k total citations
12 papers, 657 citations indexed

About

Gerd Maass is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Gerd Maass has authored 12 papers receiving a total of 657 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Immunology, 7 papers in Molecular Biology and 7 papers in Oncology. Recurrent topics in Gerd Maass's work include Immunotherapy and Immune Responses (9 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Gerd Maass is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Virus-based gene therapy research (5 papers) and CAR-T cell therapy research (5 papers). Gerd Maass collaborates with scholars based in Austria, Germany and United States. Gerd Maass's co-authors include Max L. Birnstiel, Wolfgang Schmidt, M Berger, Tamás Schweighoffer, F. Schilcher, Kurt Beyser, Ernst Wagner, M. Pedrocchi, Petra Heinmöller and Josef Rüschoff and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Immunology and Journal of Virology.

In The Last Decade

Gerd Maass

12 papers receiving 637 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gerd Maass Austria 9 289 285 268 200 120 12 657
Claire Y. Dunn United States 9 398 1.4× 194 0.7× 107 0.4× 245 1.2× 30 0.3× 11 679
Krit Ritthipichai United States 8 116 0.4× 443 1.6× 348 1.3× 97 0.5× 117 1.0× 14 792
Denis L’Abbé Canada 13 328 1.1× 51 0.2× 119 0.4× 113 0.6× 30 0.3× 20 635
Zane C. Neal United States 12 162 0.6× 167 0.6× 255 1.0× 62 0.3× 17 0.1× 17 445
Bo Luan United States 7 251 0.9× 302 1.1× 142 0.5× 69 0.3× 42 0.3× 8 540
Giovanni Barillari Italy 12 201 0.7× 166 0.6× 330 1.2× 54 0.3× 26 0.2× 30 682
A Hagiwara Japan 16 271 0.9× 188 0.7× 29 0.1× 52 0.3× 59 0.5× 34 683
John P. Riley United States 12 264 0.9× 684 2.4× 833 3.1× 178 0.9× 18 0.1× 14 1.1k
SM Baird United States 11 168 0.6× 102 0.4× 309 1.2× 118 0.6× 13 0.1× 14 595
Philip Rümke Netherlands 15 189 0.7× 217 0.8× 389 1.5× 40 0.2× 57 0.5× 22 752

Countries citing papers authored by Gerd Maass

Since Specialization
Citations

This map shows the geographic impact of Gerd Maass's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gerd Maass with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gerd Maass more than expected).

Fields of papers citing papers by Gerd Maass

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gerd Maass. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gerd Maass. The network helps show where Gerd Maass may publish in the future.

Co-authorship network of co-authors of Gerd Maass

This figure shows the co-authorship network connecting the top 25 collaborators of Gerd Maass. A scholar is included among the top collaborators of Gerd Maass based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gerd Maass. Gerd Maass is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Heinmöller, Petra, et al.. (2003). HER2 status in non-small cell lung cancer: results from patient screening for enrollment to a phase II study of herceptin.. PubMed. 9(14). 5238–43. 146 indexed citations
2.
Bogedain, C., et al.. (1997). The use of recombinant adeno-associated viral vectors for the transduction of epithelial tumor cells. International Journal of Immunopharmacology. 19(9-10). 473–479. 3 indexed citations
3.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1997). Phase I study to the immunotherapy of metastatic malignant melanoma by a cancer vaccine consisting of autologous cancer cells transfected with the human IL-2 gene. Journal of Molecular Medicine. 75(4). 297–299. 11 indexed citations
4.
Mangold, Elisabeth, Raymund Buhmann, Gerd Maass, et al.. (1997). Gene transfer of costimulatory molecules B7–1 and B7–2 into human multiple myeloma cells by recombinant adeno-associated virus enhances the cytolytic T cell response. Gene Therapy. 4(7). 726–735. 36 indexed citations
5.
Stingl, Georg, E.‐B. Bröcker, Roland Mertelsmann, et al.. (1996). Phase I Study to the Immunotherapy of Metastatic Malignant Melanoma by a Cancer Vaccine Consisting of Autologous Cancer Cells Transfected with the Human IL-2 Gene. University of Vienna, Austria. Human Gene Therapy. 7(4). 551–563. 29 indexed citations
6.
Schmidt, Wolfgang, Tamás Schweighoffer, Gerd Maass, et al.. (1995). Cancer vaccines: the interleukin 2 dosage effect.. Proceedings of the National Academy of Sciences. 92(10). 4711–4714. 103 indexed citations
7.
Zatloukal, Kurt, Achim Schneeberger, M Berger, et al.. (1995). Elicitation of a systemic and protective anti-melanoma immune response by an IL-2-based vaccine. Assessment of critical cellular and molecular parameters.. The Journal of Immunology. 154(7). 3406–3419. 76 indexed citations
8.
Maass, Gerd, Tamás Schweighoffer, M Berger, et al.. (1995). Tumor vaccines: Effects and fate of IL-2 transfected murine melanoma cells in vivo. International Journal of Immunopharmacology. 17(2). 65–73. 4 indexed citations
9.
Maass, Gerd, Wolfgang Schmidt, M Berger, et al.. (1995). Priming of tumor-specific T cells in the draining lymph nodes after immunization with interleukin 2-secreting tumor cells: three consecutive stages may be required for successful tumor vaccination.. Proceedings of the National Academy of Sciences. 92(12). 5540–5544. 83 indexed citations
10.
Cotten, Matthew, Mediyha Saltik, Malgorzata Kursa, et al.. (1994). Psoralen Treatment of Adenovirus Particles Eliminates Virus Replication and Transcription While Maintaining the Endosomolytic Activity of the Virus Capsid. Virology. 205(1). 254–261. 76 indexed citations
11.
Zatloukal, Kurt, Achim Schneeberger, M Berger, et al.. (1994). Genetic modification of cells by receptor-mediated adenovirus-augmented gene delivery: a new approach for immunotherapy of cancer.. PubMed. 78. 171–6. 3 indexed citations
12.
Zibert, Andree, Gerd Maass, Klaus Strebel, Matthias M. Falk, & Ewald Beck. (1990). Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. Journal of Virology. 64(6). 2467–2473. 87 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Claire Y. Dunn Breakdown of academic impact, for papers by Krit Ritthipichai Breakdown of academic impact, for papers by Denis L’Abbé Breakdown of academic impact, for papers by Zane C. Neal Breakdown of academic impact, for papers by Bo Luan Breakdown of academic impact, for papers by Giovanni Barillari Breakdown of academic impact, for papers by A Hagiwara Breakdown of academic impact, for papers by John P. Riley Breakdown of academic impact, for papers by SM Baird Breakdown of academic impact, for papers by Philip Rümke
Rankless by CCL
2026